Skip to main content
. 2013 Jul 18;109(4):1072–1078. doi: 10.1038/bjc.2013.389

Table 2. On-study HSR reaction characteristics.

  HSR on study
 
N=18 (%/range)
Grade
1 6 (33.3)
2 7 (38.9)
3
5 (27.8)
Symptoms
Pruritus 16 (88.9)
Rash 14 (77.8)
Chest tightness 7 (38.9)
Tachycardia 6 (33.3)
Flushing 5 (27.8)
Throat tightness 5 (27.8)
Nausea/vomiting 4 (22.2)
Hypotension 4 (22.2)
Angioedema 4 (22.2)
Dyspnea 4 (22.2)
Delayed reaction
1 (5.6)
Median carboplatin study cycle at time of initial HSR
2 (1–5)
Median cumulative carboplatin cycle at time of initial HSR
11.5 (3–22)
Outcome
Successfully continuing on study 6 (33.3)
Off carboplatin because of HSR 5 (27.8)
Off study for progression of disease 5 (27.8)
Off study for other reasons: 2 (11.1)
 Elective withdrawal 1 (5.6)
 Intolerable adverse effects 1 (5.6)

Abbreviation: HSR=hypersensitivity reaction.